Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development

Seminars in Cancer Biology

Volumn 19, Issue 4, 2009, Pages 236-243

  Ramqvist, Torbjörn ^a   Dalianis, Tina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Murine polyomavirus; Tumour specific transplantation antigen; Viral persistence; Virus like particles (VLPs)

Indexed keywords

DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CYCLE REGULATION; DNA REPLICATION; DNA TRANSCRIPTION; GENETIC TRANSFORMATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; MOUSE; NEWBORN; NONHUMAN; POLYOMA VIRUS; REVIEW; TUMOR VIRUS; VACCINATION; VIRUS PARTICLE;

ANIMALS; ANTIGENS, NEOPLASM; CELL TRANSFORMATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS; MICE; NEOPLASMS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 67349103050     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2009.02.001     Document Type: Review

References (97)

1. Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med 83 (1953) 414-421
2. Stewart S.E. Leukemia in mice produced by a filterable agent present in AKR leukemic tissues, with notes on a sarcoma produced by the same agent. Anat Rec 117 (1953) 532
3. Rowe W.P., Hartley J.W., Brodsky I., Huebner R.J., and Law L.W. Observations on the spread of mouse polyoma virus infection. Nature 182 (1958) 1617-1619
4. zur Hausen H. Other virus infections possibly involved in human cancers. In: zur Hausen H., and zur Hausen H. (Eds). Infections Causing Human Cancer (2006), Wiley-Vch Verlag Gmbh & Co., Weinheim 366-385
5. Allison A.C., and Law L.W. Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med 127 (1968) 207-212
6. Miller J.F. Influence of thymectomy on tumor induction by polyoma virus in C57bl mice. Proc Soc Exp Biol Med 116 (1964) 323-327
7. Allison A.C., and Taylor R.B. Observations on thymectomy and carcinogenesis. Cancer Res 27 (1967) 703-707
8. Vandeputte M., Denys Jr. P., Leyten R., and De Somer P. The oncogenic activity of the polyoma virus in thymectomized rats. Life Sci 7 (1963) 475-478
9. Berke Z., and Dalianis T. Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system. Adv Cancer Res 79 (2000) 249-276
10. Moller G. Studies on the development of the isoantigens of the H-2 system in newborn mice. J Immunol 86 (1961) 56-68
11. Moller G. Phenotypic expression of isoantigens of the H-2 system in embryonic and newborn mice. J Immunol 90 (1963) 271-279
12. Allison A.C. Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev 19 (1974) 3-55
13. Sjogren H.O., Hellstrom I., and Klein G. Resistance of polyoma virus immunized mice against transplantation of established polyoma tumors. Exp Cell Res 23 (1961) 204-208
14. Sjogren H.O. Studies on specific transplantation resistance to polyoma virus-induced tumors. III. Transplantation resistance to genetically compatible polyoma tumors induced by polyoma tumor homografts. J Nat Cancer Res 32 (1964) 665-749
15. Habel K. Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc Soc Exp Biol Med 106 (1961) 722-725
16. Sjogren H.O. Further studies on the induced resistance against isotransplantation of polyoma tumors. Virology 15 (1961) 214-219
17. Sjogren H.O. Studies on specific transplantation resistance to polyoma virus-induced tumors. II. Mechanism of reistance induced by polyoma virus infection. J Natl Cancer Inst 33 (1964) 375-394
18. Habel K. Polyoma tumor antigen in cells transformed in vitro by polyoma virus. Virology 18 (1962) 553-558
19. Habel K. Virus tumor antigens: specific fingerprints?. Cancer Res 26 (1966) 2018-2024
20. Sjögren H. Studies on specific transplantation resistance to polyoma virus-induced tumors. I. Transplantation resistance induced by polyoma virus infection. J Nat Cancer Inst 32 (1964) 361-374
21. Sjogren H.O. Studies on specific transplantation resistance to polyoma virus-induced tumors. IV. Stability of the polyoma cell antigen. J Natl Cancer Inst 32 (1964) 661-666
22. Dalianis T. Studies on the polyoma virus tumor-specific transplantation antigen (TSTA). Adv Cancer Res 55 (1990) 57-85
23. Ito Y. In: Klein G., Klein G., and Viral Oncology (Eds). Organization and Expression of the Genome of Polyoma Virus (1980), Raven Press, New York 447-480
24. Griffin B.E., Soeda E., Barell B.G., and Staden R. Sequence and analysis of polyoma DNA. In: Tooze J., and Tooze J. (Eds). DNA Tumour Viruses (1980), Cold Spring Harbor Lab, Cold Spring Harbor, New York 843-910
25. Cole C.N. Polyomavirinae: the viruses and their replication. In: Fields B.N., and Fields B.N. (Eds). Virology (1996), Lippincott-Raven, Philadelphia, PA 1997-2026
26. Cowie A., and Kamen R. Multiple binding sites for polyomavirus large T antigen within regulatory sequences of polyomavirus DNA. J Virol 52 (1984) 750-760
27. Land H., Parada L.F., and Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304 (1983) 596-602
28. Chen L., and Fluck M. Kinetic analysis of the steps of the polyomavirus lytic cycle. J Virol 75 (2001) 8368-8379
29. Brady J.N., Kendall J.D., and Consigli R.A. In vitro reassembly of infectious polyoma virions. J Virol 32 (1979) 640-647
30. Salunke D.M., Caspar D.L., and Garcea R.L. Self-assembly of purified polyomavirus capsid protein VP1. Cell 46 (1986) 895-904
31. Magnusson G., Nilsson M.G., Dilworth S.M., and Smolar N. Characterization of polyoma mutants with altered middle and large T-antigens. J Virol 39 (1981) 673-683
32. Griffin B.E., Ito Y., Novak U., Spurr N., Dilworth S., Smolar N., et al. Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product?. Cold Spring Harb Symp Quant Biol 44 Pt 1 (1980) 271-283
33. Benjamin T.L. Host range mutants of polyoma virus. Proc Natl Acad Sci U S A 67 (1970) 394-399
34. Dalianis T., Magnusson G., Ito Y., and Klein G. Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus. J Virol 43 (1982) 772-777
35. Ramqvist T., and Dalianis T. Polyoma virus-induced tumor-specific transplantation antigen (TSTA) is a mouse and rat cross-species-reacting antigen. Eur J Cancer Clin Oncol 20 (1984) 1557-1560
36. Treisman R., Novak U., Favaloro J., and Kamen R. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature 292 (1981) 595-600
37. Lania L., Griffiths M., Cooke B., Ito Y., and Fried M. Untransformed rat cells containing free and integrated DNA of a polyoma nontransforming (Hr-t) mutant. Cell 18 (1979) 793-802
38. Dalianis T., Ramqvist T., and Klein G. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role?. Int J Cancer 34 (1984) 403-406
39. Lathe R., Kieny M.P., Gerlinger P., Clertant P., Guizani I., Cuzin F., et al. Tumour prevention and rejection with recombinant vaccinia. Nature 326 (1987) 878-880
40. Ramqvist T., Reinholdsson G., Szigeti R., Klein G., and Dalianis T. Studies on the polyoma tumor-specific transplantation antigen (TSTA): selection and characterization of TSTA-negative segregants from somatic hybrids. Int J Cancer 40 (1987) 74-80
41. Carmichael G.G., Schaffhausen B.S., Dorsky D.I., Oliver D.B., and Benjamin T.L. Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc Natl Acad Sci U S A 79 (1982) 3579-3583
42. Ramqvist T., Pallas D.O., DeAnda J., Ahrlund-Richter L., Reinholdsson G., Roberts T.M., et al. Immunization against the polyoma tumor-specific transplantation antigen (TSTA) with polyoma T-antigens. Int J Cancer 42 (1988) 123-128
43. Reinholdsson G., Ramqvist T., Brandberg J., and Dalianis T. A polyomavirus tumor-specific transplantation antigen (TSTA) epitope is situated within the N-terminal amino acid sequence common to middle and small T-antigens. Virology 166 (1988) 616-619
44. Margalit H., Spouge J.L., Cornette J.L., Cease K.B., Delisi C., and Berzofsky J.A. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol 138 (1987) 2213-2229
45. Ramqvist T., Reinholdsson G., Carlquist M., Bergman T., and Dalianis T. A single peptide derived from the sequence common to polyoma small and middle T-antigen induces immunity against polyoma tumors. Virology 172 (1989) 359-362
46. Maloney D.G., Kaminski M.S., Burowski D., Haimovich J., and Levy R. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4 (1985) 191-209
47. Reinholdsson-Ljunggren G., Ramqvist T., Ahrlund-Richter L., and Dalianis T. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens. Int J Cancer 50 (1992) 142-146
48. Reinholdsson-Ljunggren G., and Dalianis T. Modifications of an immunodominant peptide antigen induce different anti-polyoma tumor responses in two separate mouse strains. Int J Cancer 51 (1992) 968-972
49. Reinholdsson-Ljunggren G., Franksson L., Dalianis T., and Ljunggren H.G. Identification of H-2Kb-, Db- and Dd-binding peptides derived from amino acid sequences of polyoma virus T antigens. Int J Cancer 54 (1993) 992-995
50. Chang C., Martin R.G., Livingston D.M., Luborsky S.W., Hu C.P., and Mora P.T. Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells. J Virol 29 (1979) 69-75
51. Flyer D.C., Pretell J., Campbell A.E., Liao W.S., Tevethia M.J., Taylor J.M., et al. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). X. Tumorigenic potential of mouse cells transformed by SV40 in high responder C57BL/6 mice and correlation with the persistence of SV40 TrAg, early proteins and sequences. Virology 131 (1983) 207-220
52. Campbell A.E., Foley F.L., and Tevethia S.S. Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones. J Immunol 130 (1983) 490-492
53. Tatum A.M., Mylin L.M., Bender S.J., Fischer M.A., Vigliotti B.A., Tevethia M.J., et al. CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors. J Immunol 181 (2008) 4406-4417
54. Tevethia S.S. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol Biol Med 7 (1990) 83-96
55. Mylin L.M., Deckhut A.M., Bonneau R.H., Kierstead T.D., Tevethia M.J., Simmons D.T., et al. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen. Virology 208 (1995) 159-172
56. Newmaster R.S., Mylin L.M., Fu T.M., and Tevethia S.S. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Virology 244 (1998) 427-441
57. Stoker M., and Dulbecco R. Abortive transformation by the Tsa mutant of polyoma virus. Nature 223 (1969) 397-398
58. Smolar N., and Griffin B.E. DNA sequences of polyoma virus early deletion mutants. J Virol 38 (1981) 958-967
59. Freund R., Dawe C.J., and Benjamin T.L. The middle T proteins of high and low tumor strains of polyomavirus function equivalently in tumor induction. Virology 167 (1988) 657-659
60. Dawe C.J., Freund R., Mandel G., Ballmer-Hofer K., Talmage D.A., and Benjamin T.L. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol 127 (1987) 243-261
61. Freund R., Mandel G., Carmichael G.G., Barncastle J.P., Dawe C.J., and Benjamin T.L. Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles. J Virol 61 (1987) 2232-2239
62. Lukacher A.E., Freund R., Carroll J.P., Bronson R.T., and Benjamin T.L. Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology 196 (1993) 241-248
63. Berke Z., Wen T., Klein G., and Dalianis T. Polyoma tumor development in neonatally polyoma-virus-infected CD4-/- and CD8-/- single knockout and CD4-/-8-/- double knockout mice. Int J Cancer 67 (1996) 405-408
64. Heidari S., Berke Z., Berglof A., Woldegiorgis A., Smith C.I., and Dalianis T. Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased. In Vivo 13 (1999) 439-444
65. Wirth J.J., Martin L.G., and Fluck M.M. Oncogenesis of mammary glands, skin, and bones by polyomavirus correlates with viral persistence and prolonged genome replication potential. J Virol 71 (1997) 1072-1078
66. Fried M., Griffin B.E., Lund E., and Robberson D.L. Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol 39 Pt 1 (1975) 45-52
67. Lukacher A.E., Ma Y., Carroll J.P., Abromson-Leeman S.R., Laning J.C., Dorf M.E., et al. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 181 (1995) 1683-1692
68. Wirth J.J., Amalfitano A., Gross R., Oldstone M.B., and Fluck M.M. Organ- and age-specific replication of polyomavirus in mice. J Virol 66 (1992) 3278-3286
69. Dubensky T.W., and Villarreal L.P. The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J Virol 50 (1984) 541-546
70. Dubensky T.W., Freund R., Dawe C.J., and Benjamin T.L. Polyomavirus replication in mice: influences of VP1 type and route of inoculation. J Virol 65 (1991) 342-349
71. Dubensky T.W., Murphy F.A., and Villarreal L.P. Detection of DNA and RNA virus genomes in organ systems of whole mice: patterns of mouse organ infection by polyomavirus. J Virol 50 (1984) 779-783
72. Berke Z., Dalianis T., Feinstein R., Sandstedt K., and Evengard B. Persistence of polyomavirus in adult SCID C.B-17 mice. In Vivo 8 (1994) 339-342
73. Szomolanyi-Tsuda E., and Welsh R.M. T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med 183 (1996) 403-411
74. Bosma G.C., Custer R.P., and Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature 301 (1983) 527-530
75. Bosma G.C., Davisson M.T., Ruetsch N.R., Sweet H.O., Shultz L.D., and Bosma M.J. The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. Immunogenetics 29 (1989) 54-57
76. Rahemtulla A., Fung-Leung W.P., Schilham M.W., Kundig T.M., Sambhara S.R., Narendran A., et al. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353 (1991) 180-184
77. Fung-Leung W.P., Schilham M.W., Rahemtulla A., Kundig T.M., Vollenweider M., Potter J., et al. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65 (1991) 443-449
78. Schilham M.W., Fung-Leung W.P., Rahemtulla A., Kuendig T., Zhang L., Potter J., et al. Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol 23 (1993) 1299-1304
79. Scher I. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol 33 (1982) 1-71
80. Rawlings D.J., Saffran D.C., Tsukada S., Largaespada D.A., Grimaldi J.C., Cohen L., et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261 (1993) 358-361
81. Kitamura D., Roes J., Kuhn R., and Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350 (1991) 423-426
82. Berke Z., Mellin H., Heidari S., Wen T., Berglof A., Klein G., et al. Adult X-linked immunodeficiency (XID) mice, IGM-/- single knockout and IGM-/- CD8-/- double knockout mice do not clear polyomavirus infection. In Vivo 12 (1998) 143-148
83. Berke Z., and Dalianis T. Persistence of polyomavirus in mice infected as adults differs from that observed in mice infected as newborns. J Virol 67 (1993) 4369-4371
84. Demengeot J., Jacquemier J., Torrente M., Blangy D., and Berebbi M. Pattern of polyomavirus replication from infection until tumor formation in the organs of athymic nu/nu mice. J Virol 64 (1990) 5633-5639
85. Berke Z., Wen T., Jin S., Klein G., and Dalianis T. Polyomavirus persists in CD4/8 double-knockout, but not in CD4 or CD8 single-knockout mice. Virology 212 (1995) 268-271
86. Heidari S., Krauzewicz N., Kalantari M., Vlastos A., Griffin B.E., and Dalianis T. Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus. J Virol 74 (2000) 11963-11965
87. Brady J.N., and Consigli R.A. Chromatographic separation of the polyoma virus proteins and renaturation of the isolated VP1 major capsid protein. J Virol 27 (1978) 436-442
88. Montross L., Watkins S., Moreland R.B., Mamon H., Caspar D.L., and Garcea R.L. Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J Virol 65 (1991) 4991-4998
89. Palkova Z., Adamec T., Liebl D., Stokrova J., and Forstova J. Production of polyomavirus structural protein VP1 in yeast cells and its interaction with cell structures. FEBS Lett 478 (2000) 281-289
90. Vlastos A., Andreasson K., Tegerstedt K., Hollanderova D., Heidari S., Forstova J., et al. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model. J Med Virol 70 (2003) 293-300
91. Heidari S., Vlastos A., Ramqvist T., Clark B., Griffin B.E., Garcia M.I., et al. Immunization of T-cell deficient mice against polyomavirus infection using viral pseudocapsids or temperature sensitive mutants. Vaccine 20 (2002) 1571-1578
92. Liunggren G., Liunggren H.G., and Dalianis T. T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198 (1994) 714-716
93. Berke Z., Palmer S., Bergman T., Wester D., Svedmyr J., Linder S., et al. A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J Virol 70 (1996) 3093-3097
94. Tagaram H.R., Watson A.M., Lemonnier F.A., Staveley-O'Carroll K., Tevethia S.S., and Schell T.D. An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants. Virology 376 (2008) 183-190
95. Swanson II P.A., Pack C.D., Hadley A., Wang C.R., Stroynowski I., Jensen P.E., et al. An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med 205 (2008) 1647-1657
96. Franzen A.V., Tegerstedt K., Hollanderova D., Forstova J., Ramqvist T., and Dalianis T. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours. In Vivo 19 (2005) 323-326
97. Tegerstedt K., Andreasson K., Vlastos A., Hedlund K.O., Dalianis T., and Ramqvist T. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs. J Gen Virol 84 (2003) 3443-3452